|
|
|
Insider
Information: |
Aselage Steve |
Relationship: |
Director |
City: |
Fremont |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
293,421 |
|
Indirect Shares
|
22,000 |
|
|
Direct
Value |
$6,921,325 |
|
|
Indirect Value
|
$157,085 |
|
|
Total
Shares |
315,421 |
|
|
Total
Value |
$7,078,410 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
5
|
Stock
price went up :
|
1
|
3
|
Stock
price went down : |
4
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
Percentage
Gain/Loss : |
-23.9%
|
62.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cti Biopharma Corporation |
CTIC |
EVP, Global Commercial... |
2005-06-30 |
24,133 |
2004-08-03 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Business Of... |
2012-07-02 |
59,030 |
2006-04-28 |
0 |
Premium* |
|
Travere Therapeutics, Inc |
TVTX |
Director |
2022-05-11 |
146,919 |
2021-11-05 |
19,500 |
Premium* |
|
Acer Therapeutics Inc |
ACER |
Director |
2023-11-17 |
0 |
2017-09-19 |
0 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2024-05-24 |
63,339 |
2024-05-24 |
2,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
248,732 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2020-06-01 |
4 |
A |
$4.50 |
$4,998 |
D/D |
1,112 |
26,204 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-06-25 |
4 |
AS |
$20.00 |
$200,000 |
D/D |
(10,000) |
238,732 |
0 |
% |
|
ACER |
Acer Therapeutics Inc |
Director |
|
2020-07-24 |
4 |
B |
$3.50 |
$157,500 |
D/D |
45,000 |
63,905 |
2.39 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-08-05 |
4 |
AS |
$19.68 |
$49,200 |
D/D |
(2,500) |
236,232 |
0 |
% |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2020-08-31 |
4 |
A |
$4.15 |
$9,997 |
D/D |
2,409 |
28,613 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-11-05 |
4 |
AS |
$21.26 |
$53,150 |
D/D |
(2,500) |
233,732 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-11-06 |
4 |
AS |
$23.00 |
$474,375 |
D/D |
(20,625) |
213,107 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-11-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
210,107 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2020-11-30 |
4 |
A |
$5.11 |
$9,995 |
D/D |
1,956 |
30,569 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-12-02 |
4 |
S |
$23.43 |
$184,849 |
D/D |
(7,891) |
202,216 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-12-15 |
4 |
S |
$26.02 |
$144,385 |
D/D |
(5,549) |
196,667 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-02-02 |
4 |
AS |
$30.75 |
$768,750 |
D/D |
(25,000) |
196,667 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-02-02 |
4 |
OE |
$10.09 |
$252,250 |
D/D |
25,000 |
221,667 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-02-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
164,794 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-02-04 |
4 |
GA |
$0.00 |
$0 |
I/I |
25,000 |
25,000 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-02-26 |
4 |
A |
$10.78 |
$9,993 |
D/D |
927 |
31,496 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-03-17 |
4 |
OE |
$16.23 |
$162,300 |
D/D |
10,000 |
206,667 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-03-17 |
4 |
AS |
$27.35 |
$486,456 |
D/D |
(17,727) |
188,940 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-04-16 |
4 |
AS |
$26.23 |
$262,300 |
D/D |
(10,000) |
188,940 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-04-16 |
4 |
OE |
$16.23 |
$162,300 |
D/D |
10,000 |
198,940 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-05-11 |
4 |
S |
$19.58 |
$42,023 |
D/D |
(2,146) |
186,794 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
189,794 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-05-28 |
4 |
A |
$15.77 |
$9,998 |
D/D |
634 |
32,130 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-07-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,000 |
28,000 |
0 |
- |
|
170 Records found
|
|
Page 6 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|